China Universal Asset Management Company’s Tyra Biosciences TYRA Stock Holding History

China Universal Asset Management Company’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Sell	9,465 -6	-0.1%	-$198	0.02%	322
2026 Q1	$363K	Buy	9,471 +774	+9%	+$25.1K	0.03%	293
2025 Q4	$229K	Sell	8,697 -645	-7%	-$11.8K	0.02%	337
2025 Q3	$131K	Sell	9,342 -1,339	-13%	-$15.3K	0.01%	367
2025 Q2	$102K	Buy	10,681 +531	+5%	+$5.04K	0.01%	366
2025 Q1	$94.4K	Sell	10,150 -580	-5%	-$7.5K	0.01%	361
2024 Q4	$149K	Buy	+10,730	New	+$195K	0.01%	352

Other funds holding TYRA

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

China Universal Asset Management Company's TYRA Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Tyra Biosciences (TYRA) stake by 0.06% in Q2 2026, selling an estimated $198 and leaving 9,465 shares worth $302K. The position accounts for 0.02% of the portfolio, ranked #322.

China Universal Asset Management Company first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $363K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

China Universal Asset Management Company held 9,465 shares of Tyra Biosciences worth $302K as of Q2 2026.
China Universal Asset Management Company sold 6 Tyra Biosciences shares in Q2 2026, an estimated $198.
Tyra Biosciences made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #322 holding.
China Universal Asset Management Company first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
China Universal Asset Management Company's Tyra Biosciences position peaked at $363K in Q1 2026.
168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.